Veterinary Excipients Market Report 2026

The veterinary excipients market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.05 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising demand for veterinary pharmaceuticals, increasing adoption of medicated feed additives, advancements in excipient technologies, growth in companion animal healthcare, limited standardization in excipient formulations.

The veterinary excipients market size is expected to see steady growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to expansion of functional excipients for improved drug delivery, growth in biologics and veterinary pharmaceuticals, adoption of natural and synthetic polymers, increasing focus on production animal health, integration of excipients for enhanced bioavailability and stability. Major trends in the forecast period include development of functional excipients for animal medications, growth in natural and synthetic polymers for veterinary formulations, use of lipids and phospholipids to enhance drug bioavailability, advanced preservatives and buffering agents in veterinary drugs, formulation optimization for companion and production animals.

The rise in zoonotic diseases is expected to drive the growth of the veterinary excipients market in the coming years. Zoonotic diseases are illnesses that can be transmitted from animals to humans. The increasing occurrence of these diseases is linked to factors such as habitat encroachment, climate change, intensive farming practices, wildlife trade, deforestation, poor sanitation, and broader ecosystem disruptions, creating an urgent need for effective medical interventions. Veterinary excipients play a critical role in the formulation of medications used to treat zoonotic diseases by ensuring the stability, safety, and effectiveness of active pharmaceutical ingredients in veterinary drugs. For example, in May 2025, according to the World Organisation for Animal Health (WOAH), a France-based intergovernmental animal health organization, nearly 47% of animal disease outbreaks recorded globally were capable of zoonotic transmission. The spread of diseases such as avian influenza into new regions and species highlights the growing prevalence of infections that can cross from animals to humans. Therefore, the increasing incidence of zoonotic diseases is driving the growth of the veterinary excipients market.

Major companies operating in the veterinary excipients market are focusing on developing innovative products to meet the rising demand for advanced veterinary healthcare solutions. These innovations include high-purity excipients designed to improve the stability, solubility, and performance of active pharmaceutical ingredients across a wide range of veterinary applications. For instance, in October 2023, Clariant, a Switzerland-based specialty chemicals company, launched its VitiPure range of excipients to provide flexible support for various API formulations and administration routes, including sensitive applications such as mRNA vaccines and biologics. Among these products, VitiPure O 80 Superior stands out as a high-quality polysorbate 80 with low microbial load, minimal impurities, and a colorless, odorless profile, making it well suited for demanding veterinary pharmaceutical formulations.

In August 2023, Dômes Pharma Group, a France-based pharmaceutical company, acquired SentrX Animal Care Inc. for an undisclosed amount. Through this acquisition, Dômes Pharma strengthened its global presence in veterinary healthcare, particularly in veterinary ophthalmology, and established a strategic foothold in the North American market for its therapeutic product lines. SentrX Animal Care Inc. is a U.S.-based manufacturer of veterinary products, including a range of veterinary excipients.

Major companies operating in the veterinary excipients market are Archer Daniels Midland Company, Badische Anilin- und Soda-Fabrik AG, Evonik Industries AG, DuPont de Nemours Inc., Clariant AG, Azelis India Private Limited, Lubrizol India Private Limited, Croda International Plc, Ashland Inc., JRS PHARMA GmbH & Co. KG, Vantage Specialty Chemicals, Colorcon Inc., Seppic SA, Spectrum Laboratory Products Inc., Gattefossé SAS, Quality Chemicals S.L., IOI Oleo GmbH, Lipoid LLC, Synergy API Private Limited, SSS Pharmachem Private Limited.

North America was the largest region in the veterinary excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the veterinary excipients market by increasing costs for imported polymers, lipids, alcohols, and mineral salts used in drug formulations. Segments like functional excipients for pharmaceuticals and biologics are most impacted, especially in regions such as North America, Europe, and Asia-Pacific where imports dominate. While tariffs have raised manufacturing costs, they have also encouraged domestic production, stimulated innovation in excipient formulation, and promoted development of cost-effective and locally sourced alternatives.

The veterinary excipients market research report is one of a series of new reports that provides veterinary excipients market statistics, including veterinary excipients industry global market size, regional shares, competitors with a veterinary excipients market share, detailed veterinary excipients market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary excipients industry. This veterinary excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary excipients refer to inert materials incorporated into the composition of veterinary drugs. These materials function as carriers or bases for the active components within the drug, facilitating manufacturing procedures and maintaining the medication's stability, absorption rate, and overall efficiency. Veterinary excipients play indispensable roles in animal medications, contributing significantly to their formulation, efficacy, safety, and practical application.

The primary chemical categories of veterinary excipients include polymers, alcohols, lipids, mineral salts, and others. Polymers are composed of large molecules consisting of repetitive structural units known as monomers, connected through covalent bonds. They serve multiple purposes in animals, including companion and production animals, such as fillers, binders, disintegrants, glidants, lubricants, bulking agents, buffering agents, tonicity adjusting agents, and preservatives. These applications span various uses, including biologics, pharmaceuticals, and medicated feed additives.

The veterinary excipients market consist of sales of humectants, antioxidants, solvents, and lipid-based excipients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.